Browsing Tag
Precision Medicine
26 posts
Valar Labs’ AI biomarkers validated in European Urology as superior risk predictors for bladder cancer
Valar Labs’ CHAI biomarkers validated in European Urology outperform standard methods in predicting outcomes for high grade Ta bladder cancer.
The future of biomedical research? Illumina’s spatial transcriptomics could unlock unprecedented discoveries
Illumina, Inc. has introduced an innovative spatial transcriptomics technology, designed to significantly enhance the mapping of complex tissues…
Tempus AI stock soars 14% after FDA approval of xT CDx test
Tempus AI, a leader in healthcare technology, has unveiled its FDA-approved in vitro diagnostic device, xT CDx, marking…
QIAGEN invests in new Barcelona facility to expand QIAstat-Dx capabilities
QIAGEN, a leading global provider of molecular diagnostics, has announced a multi-year investment in a new facility in…
Tempus AI shakes up precision medicine with $600m acquisition of Ambry Genetics
Tempus AI has taken a significant step in advancing its precision medicine strategy by agreeing to acquire Ambry…
Recursion Pharmaceuticals and Exscientia announce merger to transform drug development
Recursion Pharmaceuticals Inc. (Nasdaq: RXRX) and Exscientia plc (Nasdaq: EXAI) have announced a landmark merger, combining their strengths…
Tempus and AstraZeneca expand collaboration to enhance cancer care with AI
Tempus, a pioneer in artificial intelligence and precision medicine, has announced an expansion of its collaboration with pharmaceutical…
Lantern Pharma announces collaboration with Oregon Therapeutics to advance AI-driven cancer drug development
Lantern Pharma Inc. (NASDAQ: LTRN) announced a strategic collaboration with French biotech company Oregon Therapeutics to enhance the…
Diamyd Medical advances Diamyd with Phase 3 trial for Type 1 Diabetes
Diamyd Medical has achieved a significant milestone in its pioneering Phase 3 trial, DIAGNODE-3, of Diamyd in Type…
APx Acquisition announces merger with OmnigenicsAI and MultiplAI Health
In a landmark transaction for the biotechnology and AI industries, APx Acquisition Corp. I (NASDAQ: APXI), OmnigenicsAI Corp,…